[18F]FLT; portrait of a proliferation marker

European Journal of Nuclear Medicine

Volumn 29, Issue 2, 2002, Pages 165-169

  Mier, W ^a   Haberkorn, U ^a   Eisenhut, M ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

3' DEOXY 3' FLUOROTHYMIDINE F 18; CARRIER PROTEIN; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT; THYMIDINE; TRITIUM; UNCLASSIFIED DRUG; 2',3' DIDEOXYNUCLEOSIDE DERIVATIVE; 3' FLUOROTHYMIDINE; DIAGNOSTIC AGENT; FLUORINE;

CELL PROLIFERATION; DISEASE MARKER; DRUG ACCUMULATION; DRUG EXCRETION; DRUG METABOLISM; DRUG SYNTHESIS; DRUG TRANSPORT; DRUG TUMOR LEVEL; EDITORIAL; HUMAN; NONHUMAN; NUCLEOSIDE TRANSPORT; PHOSPHORYLATION; POSITRON EMISSION TOMOGRAPHY; TUMOR CELL; TUMOR CELL LINE; TUMOR GROWTH; ANIMAL; CELL DIVISION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; METABOLISM; NEOPLASM; PATHOLOGY; PHYSIOLOGY; SCINTISCANNING; SYNTHESIS;

ANIMALS; CELL DIVISION; DIDEOXYNUCLEOSIDES; FLUORINE RADIOISOTOPES; HUMANS; NEOPLASMS; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0036169353     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-001-0675-3     Document Type: Editorial

References (38)

1. Enhanced in vitro inhibition of HIV-1 replication by 3′-fluoro-3′-deoxythymidine compared to several other nucleoside analogs
2. 18F-radiolabeling, as a tracer for the non-invasive monitoring of the biodistribution of drugs against AIDS
3. 18F]fluoro-3′-deoxynucleosides
4. Radiosynthesis of 3′-deoxy-3′-[(18)F]fluorothymidine: [(18)F]FLT for imaging of cellular proliferation in vivo
5. 18F]FLT)
6. 18F]fluoro-thymidine with 2,3′-O-anhydro-5′-O-(4,4′-dimethoxytrityl)thymidine
7. 18F labeling of 3-Boc-1-(2-deoxy-3-O-nosyl-5-O-trityl-b-D-lyxofuranosyl)thymine and other thymine derivatives
8. Permeation of nucleosides, nucleic acid bases, and nucleotides in animal cells
9. Nucleoside transport in normal and neoplastic cells
10. Sodium-dependent nucleoside transport in mouse intestinal epithelial cells. Two transport systems with differing substrate specificities
11. Rates of accumulation and retention of 3-deoxy-3-fluoro-thymidine (FLT) in different cell lines
12. Thymidine kinase isoenzymes in human malignant lymphoma
13. Increased activity of thymidine kinase isozyme in human colon tumor
14. Two molecular forms of thymidine kinase in the cytosol of regenerating rat liver
15. Induction of thymidine kinases in phytohemagglutinin-stimulated lymphocytes
16. Human thymidine kinase. 1. Regulation in normal and malignant cells
17. Regulation of human thymidine kinase during the cell cycle
18. Control of thymidine kinase mRNA during the cell cycle
19. Independent regulation of thymidine kinase mRNA and enzyme levels in serum-stimulated cells
20. Regulation of thymidine kinase protein levels during myogenic withdrawal from the cell cycle is independent of mRNA regulation
21. 1) activity in human tumor cells
22. 3H]thymidine in mammalian tumor cells
23. 3′-deoxy-3′-[F-18]fluorothymidine (FLT) predicts changes in cell proliferation
24. Basis of FLT as a cell proliferation marker: Comparative uptake studies with thymidine, arabinothymidine and FDG, and cell-analysis in 22 asynchronously growing tumor cell lines
25. Mammalian deoxyribonucleoside kinases
26. Imaging proliferation in vivo with [F-18]FLT and positron emission tomography
27. 18F-FLT in patients
28. 18F]FLT uptake in tumor cells - Cell lines, mouse and rat studies
29. Thymidine concentrations in serum and urine of different animal species and man
30. Imaging with [F-18]FLT and FDG in patients with cancer
31. 18F]FLT
32. 18F]FLT-PET in brain tumors
33. Use of [F-18]FLT for imaging gastrointestinal tumors
34. 18F]FDG for tumor PET: First results of a comparative study
35. 18F]FLT for breast cancer imaging
36. F-18-fluoro-2-deoxyglucose uptake in rat prostate adenocarcinoma during chemotherapy with 2′,2′-difluoro-2′-deoxycytidine
37. Apoptosis and changes in glucose metabolism after treatment of Morris hepatoma with gemcitabine
38. Glucose transport and apoptosis after gene therapy with HSV thymidine kinase